Does DABIGATRAN ETEXILATE Cause Pulmonary embolism? 532 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 532 reports of Pulmonary embolism have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 1.4% of all adverse event reports for DABIGATRAN ETEXILATE.
532
Reports of Pulmonary embolism with DABIGATRAN ETEXILATE
1.4%
of all DABIGATRAN ETEXILATE reports
87
Deaths
318
Hospitalizations
How Dangerous Is Pulmonary embolism From DABIGATRAN ETEXILATE?
Of the 532 reports, 87 (16.4%) resulted in death, 318 (59.8%) required hospitalization, and 68 (12.8%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for DABIGATRAN ETEXILATE.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Pulmonary embolism Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB